PMID: 25764689Mar 15, 2015Paper

New era of the treatment against hepatitis C virus

Nihon rinsho. Japanese journal of clinical medicine
Mitsuteru Natsuizaka, Naoya Sakamoto

Abstract

Interferon (IFN) and ribavirin (RBV) have remained as key drugs in the treatment against hepatitis C virus (HCV) for a past decade. Although the IFN and RBV based therapy has been greatly improved, indication of the IFN based therapy is limited because of its side effects. Thus, new types of drugs against HCV have been awaited. Now many direct acting antivirals (DAAs) targeting protease, NS5A and polymerase of HCV have been developed and many clinical trials with new DAAs are ongoing. Furthermore, some of the trials have already shown outstanding results with high curative rate reaching almost 100% and very low rate of adverse events. The IFN free regimens with new DAAs would completely change the treatment against HCV.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

© 2021 Meta ULC. All rights reserved